Готові списки джерел за темами / Lactams

Зміст

Статті в журналах
Дисертації
Книги
Частини книг
Тези доповідей конференцій
Звіти організацій

Добірка наукової літератури з теми "Lactams"

Автор: Grafiati

Опубліковано: 4 червня 2021

Оновлено: 21 вересня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Lactams".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Lactams"

Li, Lu, Qiyao Wang, Hui Zhang, Minjun Yang, Mazhar I. Khan та Xiaohui Zhou. "Sensor histidine kinase is a β-lactam receptor and induces resistance to β-lactam antibiotics". Proceedings of the National Academy of Sciences 113, № 6 (1 лютого 2016): 1648–53. http://dx.doi.org/10.1073/pnas.1520300113.

Повний текст джерела

Анотація:

β-Lactams disrupt bacterial cell wall synthesis, and these agents are the most widely used antibiotics. One of the principle mechanisms by which bacteria resist the action of β-lactams is by producing β-lactamases, enzymes that degrade β-lactams. In Gram-negative bacteria, production of β-lactamases is often induced in response to the antibiotic-associated damage to the cell wall. Here, we have identified a previously unidentified mechanism that governs β-lactamase production. In the Gram-negative enteric pathogenVibrio parahaemolyticus, we found a histidine kinase/response regulator pair (VbrK/VbrR) that controls expression of a β-lactamase. Mutants lacking either VbrK or VbrR do not produce the β-lactamase and are no longer resistant to β-lactam antibiotics. Notably, VbrK autophosphorylation is activated by β-lactam antibiotics, but not by other lactams. However, single amino acid substitutions in the putative periplasmic binding pocket of VbrK leads its phosphorylation in response to both β-lactam and other lactams, suggesting that this kinase is a β-lactam receptor that can directly detect β-lactam antibiotics instead of detecting the damage to cell wall resulting from β-lactams. In strong support of this idea, we found that purified periplasmic sensor domain of VbrK binds penicillin, and that such binding is critical for VbrK autophosphorylation and β-lactamase production. Direct recognition of β-lactam antibiotics by a histidine kinase receptor may represent an evolutionarily favorable mechanism to defend against β-lactam antibiotics.

Стилі APA, Harvard, Vancouver, ISO та ін.

Medina, Marjorie B., Dana J. Poole та M. Ranae Anderson. "A Screening Method for β-Lactams in Tissues Hydrolyzed with Penicillinase I and Lactamase II". Journal of AOAC INTERNATIONAL 81, № 5 (1 вересня 1998): 963–72. http://dx.doi.org/10.1093/jaoac/81.5.963.

Повний текст джерела

Анотація:

Abstract Antibiotic residues above tolerance levels are not allowed in foods derived from farm animals. Microbial inhibition assays are used to screen antibiotics in U.S. regulatory laboratories. We developed a screening approach to classify β-lactams through selective hydrolysis of the β-lactam ring with Penase™ or lactamase II, thereby inactivating the β- lactam activity. Optimum conditions for hydrolysis of β-lactams with Penase and lactamase II were determined. p-Lactams were detected by a microbial inhibition assay and with enzyme-linked immunosorbent assays before and after hydrolysis. β- Lactams (10-100 ppb) were spiked in kidney extracts and hydrolyzed. Results indicate a pattern that tentatively classified the β-lactams into 3 subgroups. Desfuroyl-ceftiofur-cysteine, a major metabolite of ceftiofur, was clearly detected. Penicillin G, ampicillin, amoxicillin, and cloxacillin were distinguishable from cephapirin, ceftiofur metabolite, and high levels of hetacillin. Liver and kidney tissue samples were analyzed with the combined enzyme hydrolysis and screening assays, which tentatively identified the residues. This approach can speed up screening analysis of β-lactam residues prior to identification and quantitation by chromatographic analysis, thus enhancing positive identification of residues to provide a safer food supply

Стилі APA, Harvard, Vancouver, ISO та ін.

Alves, Américo J. S., Nuno G. Alves, Cátia C. Caratão, Margarida I. M. Esteves, Diana Fontinha, Inês Bártolo, Maria I. L. Soares, et al. "Spiro-Lactams as Novel Antimicrobial Agents." Current Topics in Medicinal Chemistry 20, no. 2 (February 19, 2020): 140–52. http://dx.doi.org/10.2174/1568026619666191105110049.

Повний текст джерела

Анотація:

Introduction: Structural modulation of previously identified lead spiro-β-lactams with antimicrobial activity was carried out. Objective: The main objective of this work was to synthesize and evaluate the biological activity of novel spiro-lactams based on previously identified lead compounds with antimicrobial activity. Methods: The target chiral spiro-γ-lactams were synthesized through 1,3-dipolar cycloaddition reaction of a diazo-γ-lactam with electron-deficient dipolarophiles. In vitro activity against HIV and Plasmodium of a wide range of spiro-β-lactams and spiro-γ-lactams was evaluated. Among these compounds, one derivative with good anti-HIV activity and two with promising antiplasmodial activity (IC50 < 3.5 µM) were identified. Results: A novel synthetic route to chiral spiro-γ-lactams has been established. The studied β- and γ- lactams were not cytotoxic, and three compounds with promising antimicrobial activity were identified, whose structural modulation may lead to new and more potent drugs. Conclusion: The designed structural modulation of biologically active spiro-β-lactams involved the replacement of the four-membered β-lactam ring by a five-membered γ-lactam ring. Although conformational and superimposition computational studies revealed no significant differences between β- and γ- lactam pharmacophoric features, the studied structural modulation did not lead to compounds with a similar biological profile. The observed results suggest that the β-lactamic core is a requirement for the activity against both HIV and Plasmodium.

Стилі APA, Harvard, Vancouver, ISO та ін.

Li, Xian-Zhi, Li Zhang, Ramakrishnan Srikumar та Keith Poole. "β-Lactamase Inhibitors Are Substrates for the Multidrug Efflux Pumps of Pseudomonas aeruginosa". Antimicrobial Agents and Chemotherapy 42, № 2 (1 лютого 1998): 399–403. http://dx.doi.org/10.1128/aac.42.2.399.

Повний текст джерела

Анотація:

ABSTRACT The MexAB-OprM multidrug efflux system exports a number of antimicrobial compounds, including β-lactams. In an attempt to define more fully the range of antimicrobial compounds exported by this system, and, in particular, to determine whether β-lactamase inhibitors were also accommodated by the MexAB-OprM pump, the influence of pump status (its presence or absence) on the intrinsic antibacterial activities of these compounds and on their abilities to enhance β-lactam susceptibility in intact cells was assessed. MIC determinations clearly demonstrated that all three compounds tested, clavulanate, cloxacillin, and BRL42715, were accommodated by the pump. Moreover, by using β-lactams which were readily hydrolyzed by thePseudomonas aeruginosa class C chromosomal β-lactamase, it was demonstrated that elimination of themexAB-oprM-encoded efflux system greatly enhanced the abilities of cloxacillin and BRL42715 (but not clavulanate) to increase β-lactam susceptibility. With β-lactams which were poorly hydrolyzed, however, the inhibitors failed to enhance β-lactam susceptibility in MexAB-OprM+ strains, although BRL42715 did enhance β-lactam susceptibility in MexAB-OprM−strains, suggesting that even with poorly hydrolyzed β-lactams this inhibitor was effective when it was not subjected to efflux. MexEF-OprN-overexpressing strains, but not MexCD-OprJ-overexpressing strains, also facilitated resistance to β-lactamase inhibitors, indicating that these compounds are also substrates for the MexEF-OprN pump. These data indicate that an ability to inactivate MexAB-OprM (and like efflux systems in other bacteria) will markedly enhance the efficacies of β-lactam–β-lactamase inhibitor combinations in treating bacterial infections.

Стилі APA, Harvard, Vancouver, ISO та ін.

Brilhante, R. S. N., L. G. A. Valente, M. F. G. Rocha, T. J. P. G. Bandeira, R. A. Cordeiro, R. A. C. Lima, J. J. G. Leite та ін. "Sesquiterpene Farnesol Contributes to Increased Susceptibility to β-Lactams in Strains of Burkholderia pseudomallei". Antimicrobial Agents and Chemotherapy 56, № 4 (30 січня 2012): 2198–200. http://dx.doi.org/10.1128/aac.05885-11.

Повний текст джерела

Анотація:

ABSTRACTThis study aimed to evaluate thein vitrocombination of farnesol and β-lactams againstBurkholderia pseudomallei. A total of 12 β-lactamase-positive strains were tested according to CLSI standards. All strains were inhibited by farnesol, with MICs ranging from 75 to 150 μM. The combination of this compound with β-lactams resulted in statistically significant β-lactam MIC reduction (P≤ 0.05). This study provides new perspectives for the use of farnesol combined with β-lactam antibiotics against strains ofB. pseudomallei.

Стилі APA, Harvard, Vancouver, ISO та ін.

Jacobs, Lian M. C., Patrick Consol та Yu Chen. "Drug Discovery in the Field of β-Lactams: An Academic Perspective". Antibiotics 13, № 1 (8 січня 2024): 59. http://dx.doi.org/10.3390/antibiotics13010059.

Повний текст джерела

Анотація:

β-Lactams are the most widely prescribed class of antibiotics that inhibit penicillin-binding proteins (PBPs), particularly transpeptidases that function in peptidoglycan synthesis. A major mechanism of antibiotic resistance is the production of β-lactamase enzymes, which are capable of hydrolyzing β-lactam antibiotics. There have been many efforts to counter increasing bacterial resistance against β-lactams. These studies have mainly focused on three areas: discovering novel inhibitors against β-lactamases, developing new β-lactams less susceptible to existing resistance mechanisms, and identifying non-β-lactam inhibitors against cell wall transpeptidases. Drug discovery in the β-lactam field has afforded a range of research opportunities for academia. In this review, we summarize the recent new findings on both β-lactamases and cell wall transpeptidases because these two groups of enzymes are evolutionarily and functionally connected. Many efforts to develop new β-lactams have aimed to inhibit both transpeptidases and β-lactamases, while several promising novel β-lactamase inhibitors have shown the potential to be further developed into transpeptidase inhibitors. In addition, the drug discovery progress against each group of enzymes is presented in three aspects: understanding the targets, screening methodology, and new inhibitor chemotypes. This is to offer insights into not only the advancement in this field but also the challenges, opportunities, and resources for future research. In particular, cyclic boronate compounds are now capable of inhibiting all classes of β-lactamases, while the diazabicyclooctane (DBO) series of small molecules has led to not only new β-lactamase inhibitors but potentially a new class of antibiotics by directly targeting PBPs. With the cautiously optimistic successes of a number of new β-lactamase inhibitor chemotypes and many questions remaining to be answered about the structure and function of cell wall transpeptidases, non-β-lactam transpeptidase inhibitors may usher in the next exciting phase of drug discovery in this field.

Стилі APA, Harvard, Vancouver, ISO та ін.

Sekiguchi, Jun-ichiro, Koji Morita, Tomoe Kitao, Noboru Watanabe, Mitsuhiro Okazaki, Tohru Miyoshi-Akiyama, Masato Kanamori та Teruo Kirikae. "KHM-1, a Novel Plasmid-Mediated Metallo-β-Lactamase from a Citrobacter freundii Clinical Isolate". Antimicrobial Agents and Chemotherapy 52, № 11 (2 вересня 2008): 4194–97. http://dx.doi.org/10.1128/aac.01337-07.

Повний текст джерела

Анотація:

ABSTRACT A novel gene, bla KHM-1, encoding a metallo-β-lactamase, KHM-1, was cloned from a clinical isolate of Citrobacter freundii resistant to most β-lactam antibiotics. Escherichia coli expressing bla KHM-1 was resistant to all broad-spectrum β-lactams except for monobactams and showed reduced susceptibility to carbapenems. Recombinant KHM-1 exhibited EDTA-inhibitable hydrolytic activity against most β-lactams, with an overall preference for cephalosporins.

Стилі APA, Harvard, Vancouver, ISO та ін.

Glen, Karl A., та Iain L. Lamont. "β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects". Pathogens 10, № 12 (18 грудня 2021): 1638. http://dx.doi.org/10.3390/pathogens10121638.

Повний текст джерела

Анотація:

Pseudomonas aeruginosa is a major opportunistic pathogen, causing a wide range of acute and chronic infections. β-lactam antibiotics including penicillins, carbapenems, monobactams, and cephalosporins play a key role in the treatment of P. aeruginosa infections. However, a significant number of isolates of these bacteria are resistant to β-lactams, complicating treatment of infections and leading to worse outcomes for patients. In this review, we summarize studies demonstrating the health and economic impacts associated with β-lactam-resistant P. aeruginosa. We then describe how β-lactams bind to and inhibit P. aeruginosa penicillin-binding proteins that are required for synthesis and remodelling of peptidoglycan. Resistance to β-lactams is multifactorial and can involve changes to a key target protein, penicillin-binding protein 3, that is essential for cell division; reduced uptake or increased efflux of β-lactams; degradation of β-lactam antibiotics by increased expression or altered substrate specificity of an AmpC β-lactamase, or by the acquisition of β-lactamases through horizontal gene transfer; and changes to biofilm formation and metabolism. The current understanding of these mechanisms is discussed. Lastly, important knowledge gaps are identified, and possible strategies for enhancing the effectiveness of β-lactam antibiotics in treating P. aeruginosa infections are considered.

Стилі APA, Harvard, Vancouver, ISO та ін.

Mukhopadhyay, S., and P. Chakrabarti. "Altered permeability and beta-lactam resistance in a mutant of Mycobacterium smegmatis." Antimicrobial Agents and Chemotherapy 41, no. 8 (August 1997): 1721–24. http://dx.doi.org/10.1128/aac.41.8.1721.

Повний текст джерела

Анотація:

Beta-lactam resistance in mycobacteria results from an interplay between the following: (i) beta-lactamase production, (ii) affinity of the penicillin-binding proteins (PBPs) for the drugs, and (iii) permeation of the drugs. A laboratory mutant of Mycobacterium smegmatis was studied in order to evaluate the roles of these factors in beta-lactam resistance. Mutant M13 was between 7- and 78-fold more resistant than the wild type to cephaloridine, cefoxitin, cefazolin, cefamandole, and cephalothin. Increased beta-lactamase activity toward these antibiotics was not observed in the mutant. The PBP profiles of the wild type and M13 were comparable. However, the affinities of PBP 1 for the beta-lactams tested were lower for the mutant than for the wild type. The permeation of the drugs measured in intact cells was lower for M13 than for the parent strain. The liposome swelling technique, which could be used for cephaloridine, also supported this view. Reduced permeation was not restricted to the beta-lactams alone. Glycine uptake was also lower in M13. Taken together, the results suggest that decreased affinities of PBP 1 for beta-lactams, combined with the decreased permeability of the cell wall of the mutant, lead to the development of high-level acquired beta-lactam resistance.

Стилі APA, Harvard, Vancouver, ISO та ін.

Li, Fu, Li Wan, Tongyang Xiao, Haican Liu, Yi Jiang, Xiuqin Zhao, Ruibai Wang та Kanglin Wan. "In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Mycobacterium tuberculosis Clinical Isolates". BioMed Research International 2018 (2 липня 2018): 1–8. http://dx.doi.org/10.1155/2018/3579832.

Повний текст джерела

Анотація:

Objectives. Evaluating the activity of nineteen β-lactams in combination with different β-lactamase inhibitors to determine the most potent combination against Mycobacterium tuberculosis (MTB) in vitro. Methods. Drug activity was examined by drug susceptibility test with 122 clinical isolates from China. Mutations of blaC and drug targets ldtMt1, ldtMt2, dacB2, and crfA were analyzed by nucleotide sequencing. Results. Tebipenem (TBM) in combination with clavulanate (CLA) exhibited the highest anti-TB activity. The MIC of β-lactam antibiotics was reduced most evidently in the presence of CLA, compared to avibactam (AVI) and sulbactam (SUB). Eight polymorphism sites were identified in blaC, which were not associated with β-lactams resistance. Interestingly, one strain carrying G514A mutation in blaC was highly susceptible to β-lactams regardless of the presence of inhibitors. The transpeptidase encoding genes, ldtMt1, ldtMt2, and dacB2, harboured three mutations, two mutations, and one mutation, respectively, but no correlation was found between these mutations and drug resistance. Conclusion. The activity of β-lactams against MTB and different synergetic effect of β-lactamase inhibitors were indicated. TBM/CLA exhibited the most activity and has a great prospect in developing novel anti-TB regimen; however, further clinical research is warranted. Moreover, the resistance to the β-lactam antibiotics might not be conferred by single target mutation in MTB and requires further studies.

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Lactams"

Betou, Marie. "Semipinacol rearrangement of cis-fused β-lactam diols into bicyclic lactams". Thesis, University of Birmingham, 2013. http://etheses.bham.ac.uk//id/eprint/4348/.

Повний текст джерела

Анотація:

The 6-azabicyclo[3.2.1]octane ring system is found in a wide variety of biologically active natural and non-natural products. The aim of this project is to prepare the 7,8-diketo-6-azabicyclo[3.2.1]octane structure via a semipinacol rearrangement of ring-fused β -lactams. Chapter 1 introduces the pinacol and semipinacol rearrangement, including the use of cyclic sulfites and phosphoranes, and ring expansion of β -lactams. Previous work in the Grainger group for the synthesis of lactams via tandem radical cyclisation-dithiocarbamate group transfer is also discussed. Chapter 2 describes the methodology developed for the semipinacol rearrangement of β-lactams. Access to suitable precursors for the semipinacol rearrangement is achieved through a sequence of 4-exo trig radical cyclisation, base-mediated dithiocarbamate group elimination and dihydroxylation. Formation of the 7,8-diketo-6-azabicyclo[3.2.1]octane ring system occurs through semipinacol rearrangement of the corresponding cyclic sulfites and phosphoranes. In Chapter 3, the scope and limitations of the methodology are explored. Different substituents on the nitrogen of the β-lactam, groups on the cyclohexane moiety (methyl and oxygenation) and ring sizes are investigated. An original approach to the total synthesis of peduncularine is described in Chapter 4. Synthesis of a suitably functionalised β-lactam and attempts to further transform it into the desired 7,8-diketo-6- azabicyclo[3.2.1]oct-3-ene structure are reported. Work towards the total synthesis of calyciphylline D, calyciphylline F and caldaphnidine M is described in chapter 5. Reductive amination and stereoselective reduction of piperitone are investigated. Use of a model system for the addition of nucleophiles onto thiolactams is also described.

Стилі APA, Harvard, Vancouver, ISO та ін.

Warren, H. A. "New routes to sugar lactams, lactim ethers and cyclic amidines." Thesis, Swansea University, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.639351.

Повний текст джерела

Анотація:

Chapter 1 introduces the biological importance of glycosidase inhibitors. The biosynthesis of N-linked glycoproteins is briefly described and the mode of action of glycosidase enzymes is discussed. Some naturally occurring amino-sugar glycosidase inhibitors are detailed. In addition certain sugar lactones, lactams and cyclic amidines which have also been shown to inhibit glycosidase enzymes are reviewed. Chapter 2 introduces the syntheses of various polyhydroxylated piperidine and pyrrolidine alkaloids and sugar lactams. In addition the formation of cyclic sugar amidines and their derivatives is discussed. Chapter 3 involves the syntheses of four novel sugar lactams. The syntheses of 4-amino-4-deoxy-D-allonolactam and 4-amino-4-deoxy-D-talonolactam via novel routes developed by the author are dealt with in detail. The preparations of the corresponding D- and L-ribono compounds by a shortening of the carbon chain are also described. Chapter 4 introduces the syntheses of the novel D-allono-, D-talono- and D-ribono- amidines from the corresponding lactam derivatives. Chapter 4 also reports on literature preparations of sugar tetrazoles and their inhibitory properties towards glycosidase enzymes. Also included is the synthesis of the novel D-talonotetrazole.

Стилі APA, Harvard, Vancouver, ISO та ін.

Guignard, Guillaume Michel Pablo. "Open-chain building blocks from chiral lactams. Enantioselective synthesis of macrocyclic nitrogen-containing natural products." Doctoral thesis, Universitat de Barcelona, 2016. http://hdl.handle.net/10803/396650.

Повний текст джерела

Анотація:

1. (R)-Phenylglycinol-derived oxazolopiperidone lactams can be converted to enantiopure open-chain amino ester scaffolds by alkaline hydrolysis of the N-Boc 2-piperidones resulting from the reductive cleavage of the oxazolidine ring. 2. Lithium amidotrihydroborate (LiNH2BH3) reduction of diversely substituted (R)-phenylglycinol-derived oxazolopiperidone lactams brought about the reductive opening of both the oxazolidine and lactam rings, providing general access to structurally diverse enantiopure amino diols A bearing a variety of substitution patterns, substituents (alkyl, benzyl, aryl, protected hydroxy), and stereochemistries. 3. Reductive removal of the phenylethanol moiety present in the amino diols prepared by the above procedure, followed by treatment of the resulting primary amines with (Boc)2O provides a general synthetic entry to enantiopure N-Boc 5-aminopentanols bearing substitutents at the 2-, 3-, 4-, 2,2-, 2,3-, 2,4-, and 3,4- positions. 4. The oxidative removal of the phenylglycinol moiety of amino diols A (previously O-silylated) using the I2/aq NH3 system constitutes an excellent procedure for the straightforward preparation of enantiopure substituted 5-hydroxypentanenitrile derivatives. 5. The m-CPBA-promoted oxidative removal of the phenylglycinol moiety of amino diols A (previously O-silylated) constitutes an excellent procedure for the straightforward preparation of enantiopure substituted 5-hydroxypentanoic acid derivatives. 6. As both enantiomers of phenylglycinol are commercially available, both enantiomers of a target 5-aminopentanol, 5-hydroxypentanoic acid, and 5-hydroxypentanenitrile are accessible through the above methodology. 7. The synthetic value of the open-chain amino diols A has been demonstrated with their use as key scaffolds for the enantioselective synthesis of the Haliclona alkaloids haliclorensin C (first total synthesis), haliclorensin (total), halitulin (formal), and isohaliclorensin (formal). 8. The synthetic value of the open-chain amino diols 5-hydroxypentanoic acids, and 5-hydroxypentanenitriles prepared from (S)-phenylglycinol-derived lactams has been demonstrated with their use as key scaffolds for the synthesis of the natural macrolactam fluvirucinin B1. 9. The approach we have developed significantly expands the potential of phenylglycinol-derived d-lactams, which have been converted for the first time to enantiopure open-chain building blocks.

Стилі APA, Harvard, Vancouver, ISO та ін.

Sheppard, L. N. "Synthesis of B-lactams." Thesis, University of Oxford, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.354855.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

McKenna, Jeffrey M. "Asymmetric synthesis of #beta#-lactams." Thesis, University of Oxford, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.240681.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Goh, Kee Chuan. "The biosynthesis of β-lactams". Thesis, University of Oxford, 1993. http://ora.ox.ac.uk/objects/uuid:24b6b29d-87cc-48f2-bd1b-bb64c663604f.

Повний текст джерела

Анотація:

This thesis reports the work done on two research projects which were carried out independently of each other but converge on the central theme of β-lactam biosynthesis. Chapter 1 provides an overview of biosynthesis in secondary metabolism, with special emphasis on current knowledge about the β-lactams. The first project, covered from Chapters 2 to 5, was part of our group's continuing effort to understand the structure and mechanism of Ring Expandase-Hydroxylase (REXH), an enzyme involved in the biosynthesis of cephalosporin C in Cephalosporium acremonium. REXH is a bifunctional enzyme, converting penicillin N to DAOC and thence to DAC. [diagram omitted from transcription] Chapter 3 discusses the investigation of purification protocols for native REXH and soluble recombinant REXH, as well as an improved refolding method for recombinant REXH expressed as inclusion bodies. Chapter 4 describes two new alternative substrates for REXH, viz. carba-DAOC and DAC, whilst the y-lactam analogue of penicillin N was not found to be a substrate for REXH. Chapter 5 summarises some structural investigations of REXH employing methods such as electrospray mass spectrometry, selective proteolysis and inhibition kinetics. [diagram omitted from transcription] The second project, covered from Chapters 6 to 9, represents the first biosynthetic studies on valclavam, an antifungal produced by Streptomyces antibioticus. Valclavam belongs to the family of clavams which includes clavulanic acid as its most well studied member. [diagram omitted from transcription] Chapter 7 details the development of methods for the bioassay, fermentation and isolation of valclavam. It also describes the isolation of a stable degradation fragment of valclavam which led to the revision of the structures of valclavam and Tü 1718B (another metabolite from the same organism). Chapter 8 gives an account of the whole-cell feeding experiments which strongly suggest that the primary metabolic precursors for valclavam are L-valine, L-arginine, L-methionine and glycerol. Chapter 9 reports the discovery of two enzymic activities, belonging to those of clavaminic acid synthase and proclavaminic acid amidino hydrolase, which are likely to be involved in the biosynthesis of valclavam. Together, the results of Chapters 8 and 9 point to an extensive overlap between the clavulanic acid pathway in Streptomyces clavuligerus and the valclavam pathway in Streptomyces antibioticus.

Стилі APA, Harvard, Vancouver, ISO та ін.

Welchman, Elizabeth Victoria. "The chemistry of Î² lactams." Thesis, University of Sunderland, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.247775.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Walker, Matthew David. "Diastereoselective reactions of atropisomeric lactams." Thesis, University of Nottingham, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.247569.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Pearson, C. J. "Synthesis of aza-beta-lactams." Thesis, Imperial College London, 1985. http://hdl.handle.net/10044/1/37815.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Joshi, S. N. "Diastereoselective synthesis of β-lactams". Thesis(Ph.D.), CSIR-National Chemical Laboratory, Pune, 2000. http://dspace.ncl.res.in:8080/xmlui/handle/20.500.12252/2271.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Книги з теми "Lactams"

Ogliaruso, Michael A. Synthesis of lactones and lactams. Chichester: Wiley, 1993.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bellido, F. The new -lactams: Mode of action, mechanisms of resistance. Basle, Switzerland: Roche, 1989.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Banik, Bimal K., ed. Beta-Lactams. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Alcaide, B., and Bimal K. Banik. Heterocyclic scaffolds I: Ss-lactams. Heidelberg: Springer, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Janecki, Tomasz, ed. Natural Lactones and Lactams. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2013. http://dx.doi.org/10.1002/9783527666911.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Hamao, Umezawa, Takeda Kagaku Shinkō Zaidan, and Takeda Science Foundation Symposium (4th : 1986 : Kyoto, Japan), eds. Frontiers of antibiotic research. Tokyo: Academic Press, 1987.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Page, Michael I., ред. The Chemistry of β-Lactams. Dordrecht: Springer Netherlands, 1992. http://dx.doi.org/10.1007/978-94-011-2928-2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

I, Page Michael, ed. The Chemistry of [beta]-lactams. London: Blackie Academic & Professional, 1992.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Alle, Bruggink, ed. Synthesis of [beta]-lactam antibiotics: Chemistry, biocatalysis & process integration. Dordrecht: Kluwer Academic Publishers, 2001.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ogliaruso, Michael A., and James F. Wolfe, eds. Synthesis of Lactones and Lactams (1993). Chichester, UK: John Wiley & Sons, Inc., 1993. http://dx.doi.org/10.1002/9780470772522.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Частини книг з теми "Lactams"

Singh, Girija S., and Siji Sudheesh. "β-Lactams." In Natural Lactones and Lactams, 101–45. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2013. http://dx.doi.org/10.1002/9783527666911.ch3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bhalla, Aman, Shamsher S. Bari, and Jitender Bhalla. "Synthesis of Diverse β-Lactams: Role of Appended Hetero Moiety on Its Activity." In Beta-Lactams, 1–39. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Sowinska, Marta, Maja Morawiak, Zofia Urbanczyk-Lipkowska, and Jolanta Solecka. "Nanochemistry in Drug Design." In Beta-Lactams, 311–34. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5_10.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Palomo, Claudio, and Mikel Oiarbide. "Asymmetric Synthesis of β-Lactams via the Ketene-Imine Cycloaddition." In Beta-Lactams, 335–72. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5_11.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bhattacharya, Prabuddha, Sansa Dutta, Koushik Chandra, and Amit Basak. "The Never-Ending Story of β-Lactams: Use as Molecular Scaffolds and Building Blocks." In Beta-Lactams, 373–419. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5_12.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bari, Shamsher S., Aman Bhalla, and Jitender Bhalla. "Role of Transition Metal Reagents in β-Lactam Synthesis: New Paradigms." In Beta-Lactams, 41–71. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5_2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Klimczak, Urszula, Bartłomiej Furman, and Bartosz Zambroń. "4-Vinyloxyazetidin-2-one, a Novel Substrate for β-Lactam Synthesis." In Beta-Lactams, 73–104. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5_3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Tidwell, Thomas T. "β-Lactams from Ketene-Imine Cycloadditions: An Update." In Beta-Lactams, 105–28. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5_4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Delpiccolo, Carina M. L., Maitena Martinez-Amezaga, and Ernesto G. Mata. "Recent Approaches Toward the Generation of Molecular Diversity Based on β-Lactam Structures." In Beta-Lactams, 129–62. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5_5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Alcaide, Benito, Pedro Almendros, and Cristina Aragoncillo. "Synthesis of Five-Membered Heterocycles Through β-Lactam Ring-Expansion Reaction." In Beta-Lactams, 163–218. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55621-5_6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Lactams"

McLoughlin, Eavan, Niamh O'Boyle, and Mary Meegan. "Stories from Staudinger: Synthesis of chiral beta-lactams." In 5th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2019. http://dx.doi.org/10.3390/ecmc2019-06402.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Kupka, Teobald, Piotr Lodowski, Maria Jaworska та Jan O. Dzięgielewski. "Semi empirical PM3 and spectroscopic studies on β-lactams". У The first European conference on computational chemistry (E.C.C.C.1). AIP, 1995. http://dx.doi.org/10.1063/1.47686.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Espadinha, Margarida, Jorge Dourado, Rocio Lajarin-Cuesta, Clara Herrera- Arozamena, Lídia Gonçalves, João Lopes, María Rodríguez-Franco, Daniel J. V. A. dos Santos, Cristobal de los Rios, and Maria M. M. Santos. "Bicyclic lactams as potential inhibitors of the NMDA receptor." In 4th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2018. http://dx.doi.org/10.3390/ecmc-4-05631.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

McLoughlin, Eavan, та Niamh O'Boyle. "Enantiomeric β-Lactams for the Treatment of Breast Cancer". У 6th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2020. http://dx.doi.org/10.3390/ecmc2020-07507.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Couture, Axel, Pierre Grandclaudon, Stéphane Lebrun та Gwenaëlle Liberge. "Convenient synthesis of functionalized α-methylenebutano-4-lactams or lactones". У The 15th International Electronic Conference on Synthetic Organic Chemistry. Basel, Switzerland: MDPI, 2011. http://dx.doi.org/10.3390/ecsoc-15-00570.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Abood, Zeid Hassan, Amani Nadhim Kadhim та Husham Attallah Suhail. "Microwave assisted synthesis of new β-Lactams bearing thiadiazole moiety". У 4TH INTERNATIONAL SCIENTIFIC CONFERENCE OF ENGINEERING SCIENCES AND ADVANCES TECHNOLOGIES. AIP Publishing, 2023. http://dx.doi.org/10.1063/5.0157220.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

K. Alkhudhairy, Miaad, та Elhassan Benyagoub. "Frequency of Genes Mediated β-lactams Resistance in Acinetobacter Baumannii Isolates from Iraq". У X INTERNATIONAL CONGRESS OF PURE AND APPLIED TECHNOLOGICAL SCIENCES. Rimar Academy, 2023. http://dx.doi.org/10.47832/minarcongress10-2.

Повний текст джерела

Анотація:

Background: Acinetobacter baumannii is a nosocomial virulent microorganism that can cause acute and chronic infections in burn patients. The aim of the study: Diagnosis of genes mediated β-lactams resistance among test isolates. Materials and Methods: 649 swabs collected from inpatients with burn-wound infections at a burn center in Al-Najaf Province/ Iraq, from August 2022 to February 2023. Results: 68/ 649 (10.5%) isolates of Acinetobacter baumannii were identified according to microscopically, cultural, and biochemical features. 22 (32.4%) isolates were found able to produce extended-spectrum β-lactamases by using the double disks synergy method, and these producers tested by polymerase chain reactions technique for molecular determination β-lactams resistance encoding genes. This technique determined that the frequency of a single blaTEM gene and a single blaCTXM gene was 3/ 22 (13.6%) for each one among the test isolates and that 9/ 22 (41%) isolates possessed linked genes: the blaCTXM and blaTEM genes, whereas the blaSHV gene was not identified in any test isolate. Conclusions: The co-associated (blaTEM and blaCTXM) genes were revealed to be prevalent among the test isolates

Стилі APA, Harvard, Vancouver, ISO та ін.

Rezali, Nurul Syafiqah. "The Syntheses Of Fused Cyclic 5/6-Membered Ring Lactams Via Enamine Hydrogenation." In 8th International Conference on Multidisciplinary Research 2019. European Publisher, 2020. http://dx.doi.org/10.15405/epsbs.2020.03.03.87.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Khalifa, Abdulrhman Y., Mahmood Sh Magtoof та Husam M. Kredy. "Synthesis, spectral characterization, antioxidant and anticancer evaluation of 1, 2, 3-trisubstituted-γ-lactams". У PROCEEDING OF THE 1ST INTERNATIONAL CONFERENCE ON ADVANCED RESEARCH IN PURE AND APPLIED SCIENCE (ICARPAS2021): Third Annual Conference of Al-Muthanna University/College of Science. AIP Publishing, 2022. http://dx.doi.org/10.1063/5.0093789.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Prickett, Michelle, Joanne Cullina, Anna Lam, and Manu Jain. "The Effects Of Single Agent Therapy With ²-lactams For Severe Cystic Fibrosis Exacerbations During Pregnancy." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1815.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Lactams"

Cang, Huai Qin, XiangHua Quan, XiangHua Chu, Yu Liang, Xue Yang та Jing Li. Carbapenems versus β-lactam and β-lactamase inhibitors for treatment of Nosocomial Pneumonia: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, квітень 2023. http://dx.doi.org/10.37766/inplasy2023.4.0113.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Chiu, Chia-Yu, and Amara Sarwal. Impact of area under the curve-based vancomycin dosing combination with anti-pseudomonal beta-lactam antibiotics: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0025.

Повний текст джерела

Анотація:

Review question / Objective: Did AUC-based vancomycin dosing reduce acute kidney injury than trough-based dosing when combined with anti-pseudomonal beta-lactam antibiotic? Condition being studied: Patients received Vancomycin combined with anti-pseudomonal beta-lactam antibiotics and monitor with either trough-base dosing or AUC-based dosing vancomycin. Information sources: All study types except case reports, case series, and conference abstracts were considered. PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched from inception to November2022.

Стилі APA, Harvard, Vancouver, ISO та ін.

Mosher, Jennifer J., Meghan M. Drake, Susan L. Carroll, Zamin K. Yang, Christopher W. Schadt, Stephen D. Brown, Mircea Podar, et al. Microbial Community Dynamics of Lactate Enriched Hanford Groundwaters. Office of Scientific and Technical Information (OSTI), May 2010. http://dx.doi.org/10.2172/986244.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Meyer, Birte, and David Stahl. Syntrophic Degradation of Lactate in Methanogenic Co-cultures. Office of Scientific and Technical Information (OSTI), May 2010. http://dx.doi.org/10.2172/986317.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ma, Lianjia. Multichannel Simultaneous Determination of Activities of Lactate Dehydrogenase. Office of Scientific and Technical Information (OSTI), September 2000. http://dx.doi.org/10.2172/764689.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Li, Yuan, Benjamin Metcalf, Sopio Chochua, Zhongya Li, Robert Gertz, Hollis Walker, Paulina Hawkins, Theresa Tran, Lesley McGee та Bernard W. Beall. Validation of β-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequences [Supporting data]. Centers for Disease Control and Prevention (U.S.), листопад 2017. http://dx.doi.org/10.15620/cdc/147467.

Повний текст джерела

Анотація:

The datafiles, R scripts, MIC tables, and other files were used to evaluate the prediction performance of a penicillin-binding protein (PBP) typing system and two methods (Random Forest (RF) and Mode MIC (MM) previously developed by this research team. This data and these files support the finding of the paper "Validation of β-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequences" at https://doi.org/10.1186%2Fs12864-017-4017-7 or at https://stacks.cdc.gov/view/cdc/47684.

Стилі APA, Harvard, Vancouver, ISO та ін.

Piper, Robert C. Parasite Lactate Dehydrogenase for Diagnosis of Plasmodium Falciparum. Phase II. Fort Belvoir, VA: Defense Technical Information Center, April 1997. http://dx.doi.org/10.21236/adb230017.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Kim, Yuan, Edward M. Steadham, Steven M. Lonergan, and Elisabeth J. Huff-Lonergan. Antioxidant Capacity of Calcium Lactate on m-Calpain Activity In Vitro. Ames (Iowa): Iowa State University, January 2009. http://dx.doi.org/10.31274/ans_air-180814-1237.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Reeves, John T. Beta-Adrenergic Blockade and Lactate Metabolism during Exercise at High Altitude. Fort Belvoir, VA: Defense Technical Information Center, January 1993. http://dx.doi.org/10.21236/ada263544.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Dou, Q. P. Synthetic Beta-Lactam Antibiotics as a Selective Breast Cancer Cell Apoptosis Inducer: Significance in Breast Cancer Prevention and Treatment. Fort Belvoir, VA: Defense Technical Information Center, March 2007. http://dx.doi.org/10.21236/ada572620.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!